Thrombotic Thrombocytopenic Purpura: A Thrombotic Disorder Caused by ADAMTS13 Deficiency

Moschcowitz, 1925, An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease, Arch Intern Med, 36, 89, 10.1001/archinte.1925.00120130092009 Rock, 1991, Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med, 325, 393, 10.1056/NEJM199108083250604 Tapper, 1995, Lessons learned in the management of hemolytic uremic syndrome in children, J Pediatr Surg, 30, 158, 10.1016/0022-3468(95)90554-5 Vesely, 2003, ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients, Blood, 102, 60, 10.1182/blood-2003-01-0193 Remuzzi, 2002, von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, Blood, 100, 778, 10.1182/blood-2001-12-0166 Bukowski, 1982, Thrombocytopenic purpura. A review, Prog Hemost Thromb, 6, 287 Levy, 2001, Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, 413, 488, 10.1038/35097008 Soejima, 2001, A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?, J Biochem (Tokyo), 130, 475, 10.1093/oxfordjournals.jbchem.a003009 Zheng, 2001, Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura, J Biol Chem, 276, 41059, 10.1074/jbc.C100515200 Zhou, 2005, ADAMTS13 is expressed in hepatic stellate cells, Lab Invest, 85, 780, 10.1038/labinvest.3700275 Uemura, 2005, Localization of ADAMTS13 to the stellate cells of human liver, Blood, 106, 922, 10.1182/blood-2005-01-0152 Suzuki, 2004, Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets, Biochem Biophys Res Commun, 313, 212, 10.1016/j.bbrc.2003.11.111 Liu, 2005, Platelet-derived VWF-cleaving metalloprotease ADAMTS-13, J Thromb Haemost, 3, 2536, 10.1111/j.1538-7836.2005.01561.x Turner, 2006, Human endothelial cells synthesize and release ADAMTS-13, J Thromb Haemost, 4, 1396, 10.1111/j.1538-7836.2006.01959.x Tsai, 1997, Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1, Blood, 89, 1954, 10.1182/blood.V89.6.1954 Crawley, 2005, Proteolytic inactivation of ADAMTS13 by thrombin and plasmin, Blood, 105, 1085, 10.1182/blood-2004-03-1101 Studt, 2005, Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin, Blood, 105, 542, 10.1182/blood-2004-06-2096 Bonnefoy, 2006, Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13, Blood, 107, 955, 10.1182/blood-2004-12-4856 Apte, 2004, A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family, Int J Biochem Cell Biol, 36, 981, 10.1016/j.biocel.2004.01.014 Nicholson, 2005, Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization, BMC Evol Biol, 5, 11, 10.1186/1471-2148-5-11 Majerus, 2003, Cleavage of the ADAMTS13 propeptide is not required for protease activity, J Biol Chem, 278, 46643, 10.1074/jbc.M309872200 Zhou, 2005, Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?, J Biol Chem, 280, 39934, 10.1074/jbc.M504919200 Zheng, 2003, Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13, J Biol Chem, 278, 30136, 10.1074/jbc.M305331200 Soejima, 2003, ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage, Blood, 102, 3232, 10.1182/blood-2003-03-0908 Gao, 2006, Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease, Proc Natl Acad Sci USA, 103, 19099, 10.1073/pnas.0607264104 Luken, 2005, The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura, Thromb Haemost, 93, 267, 10.1160/TH04-05-0301 Klaus, 2004, Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura, Blood, 103, 4514, 10.1182/blood-2003-12-4165 Tsai, 2003, Shear stress and von Willebrand factor in health and disease, Semin Thromb Hemost, 29, 479, 10.1055/s-2003-44556 Tsai, 1998, Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203 Ruggeri, 2006, Activation-independent platelet adhesion and aggregation under elevated shear stress, Blood, 108, 1903, 10.1182/blood-2006-04-011551 Weiss, 1978, Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate–dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome, J Lab Clin Med, 92, 750 Chauhan, 2006, Systemic antithrombotic effects of ADAMTS13, J Exp Med, 203, 767, 10.1084/jem.20051732 Dong, 2002, ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions, Blood, 100, 4033, 10.1182/blood-2002-05-1401 Motto, 2005, Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice, J Clin Invest, 115, 2752, 10.1172/JCI26007 Furlan, 1998, Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839, 10.1182/blood.V91.8.2839.2839_2839_2846 Furlan, 1998, von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N Engl J Med, 339, 1578, 10.1056/NEJM199811263392202 Tsai, 2006, ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura, Thromb Haemost, 95, 886, 10.1160/TH06-02-0100 Zhou, 2004, An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations, Thromb Haemost, 91, 806, 10.1160/TH03-11-0675 Rick, 2002, Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura, Thromb Haemost, 88, 598 Veyradier, 2001, Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, 98, 1765, 10.1182/blood.V98.6.1765 Bohm, 2002, Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13), Ann Hematol, 81, 430, 10.1007/s00277-002-0502-3 Hovinga, 2004, von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience, Semin Hematol, 41, 75, 10.1053/j.seminhematol.2003.10.008 Matsumoto, 2004, The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Semin Hematol, 41, 68, 10.1053/j.seminhematol.2003.10.009 Coppo, 2004, Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement, Medicine (Baltimore), 83, 233, 10.1097/01.md.0000133622.03370.07 Terrell, 2005, The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency, J Thromb Haemost, 3, 1432, 10.1111/j.1538-7836.2005.01436.x Peyvandi, 2004, von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura, Br J Haematol, 127, 433, 10.1111/j.1365-2141.2004.05217.x Kokame, 2005, FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay, Br J Haematol, 129, 93, 10.1111/j.1365-2141.2005.05420.x Zheng, 2004, Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura, Blood, 103, 4043, 10.1182/blood-2003-11-4035 Uemura, 2005, Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis, Alcohol Clin Exp Res, 29, 264S, 10.1097/01.alc.0000192326.08931.cb Ono, 2006, Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure, Blood, 107, 528, 10.1182/blood-2005-03-1087 Nguyen, 2007, Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis, Haematologica, 92, 121, 10.3324/haematol.10262 Bianchi, 2002, Von von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura, Blood, 100, 710, 10.1182/blood-2002-02-0344 Lisman, 2006, Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity, Hepatology, 44, 53, 10.1002/hep.21231 Banno, 2006, Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura, Blood, 107, 3161, 10.1182/blood-2005-07-2765 Torok, 1995, Increasing mortality from thrombotic thrombocytopenic purpura in the United States–analysis of national mortality data, 1968–1991, Am J Hematol, 50, 84 Miller, 2004, Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, Epidemiology, 15, 208, 10.1097/01.ede.0000113273.14807.53 Schech, 2006, New-onset and idiopathic thrombotic thrombocytopenic purpura: incidence, diagnostic validity, and potential risk factors, Am J Hematol, 81, 657, 10.1002/ajh.20669 Hymes, 1997, Human immunodeficiency virus infection and thrombotic microangiopathy, Semin Hematol, 34, 117 Bennett, 1998, Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases, Ann Intern Med, 128, 541, 10.7326/0003-4819-128-7-199804010-00004 Tsai, 2000, Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura, Ann Intern Med, 132, 794, 10.7326/0003-4819-132-10-200005160-00005 Bennett, 2000, Thrombotic thrombocytopenic purpura associated with clopidogrel, N Engl J Med, 342, 1773, 10.1056/NEJM200006153422402 Zakarija, 2004, Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration, Stroke, 35, 533, 10.1161/01.STR.0000109253.66918.5E Ridolfi, 1979, The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients, Ann Intern Med, 91, 357, 10.7326/0003-4819-91-3-357 Podolsky, 1999, Massive myocardial necrosis in thrombotic thrombocytopenic purpura: a case report and review of the literature, Arch Pathol Lab Med, 123, 937, 10.5858/1999-123-0937-MMNITT Downes, 2004, Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident, J Clin Apheresis, 19, 86, 10.1002/jca.20007 Kennedy, 1980, Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases, Semin Thromb Hemost, 6, 341, 10.1055/s-2007-1005107 Mannucci, 2003, Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis), Haematologica, 88, 914 Sill, 1995, Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura), Cancer, 75, 1167, 10.1002/1097-0142(19950301)75:5<1167::AID-CNCR2820750517>3.0.CO;2-1 Lin, 1995, Microangiopathic hemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin, South Med J, 88, 683, 10.1097/00007611-199506000-00021 Fontana, 2001, Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease, Br J Haematol, 113, 100, 10.1046/j.1365-2141.2001.02704.x Forman, 2003, Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy, Acta Haematol, 109, 150, 10.1159/000069291 Sinha, 2005, Haemolytic uraemic syndrome following acute pancreatitis, JOP, 6, 365 Moake, 1989, Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, Am J Med, 87, 9N Tsai, 2001, von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome, Pediatr Res, 49, 653, 10.1203/00006450-200105000-00008 Veyradier, 2000, Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension, Circulation, 102, 2460, 10.1161/01.CIR.102.20.2460 Vincentelli, 2003, Acquired von Willebrand syndrome in aortic stenosis, N Engl J Med, 349, 343, 10.1056/NEJMoa022831 Tripodi, 2004, Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas, J Thromb Haemost, 2, 1601, 10.1111/j.1538-7836.2004.00879.x Rieger, 2006, Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA), Thromb Haemost, 95, 212, 10.1160/TH05-08-0550 Shelat, 2006, Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo, J Thromb Haemost, 4, 1707, 10.1111/j.1538-7836.2006.02025.x Tsai, 2001, Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura, Clin Lab, 47, 387 Rieger, 2005, ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases, Blood, 106, 1262, 10.1182/blood-2004-11-4490 Byrnes, 1990, Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura, Am J Hematol, 34, 169, 10.1002/ajh.2830340303 Yarranton, 2004, Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura, Transfus Med, 14, 39, 10.1111/j.0958-7578.2004.00478.x Scott, 2007, Comparison and stability of ADAMTS13 activity in therapeutic plasma products, Transfusion, 47, 120, 10.1111/j.1537-2995.2007.01074.x Allford, 2000, Von Willebrand factor–cleaving protease activity in congenital thrombotic thrombocytopenic purpura, Br J Haematol, 111, 1215, 10.1046/j.1365-2141.2000.02503.x Zeigler, 2001, Cryoprecipitate-poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP), J Clin Apheresis, 16, 19, 10.1002/jca.1003 Rock, 2005, Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet, Br J Haematol, 129, 79, 10.1111/j.1365-2141.2005.05418.x Tsai, 1996, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood, 87, 4235, 10.1182/blood.V87.10.4235.bloodjournal87104235 Bobbio-Pallavicini, 1997, Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP, Haematologica, 82, 429 Allford, 2003, Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias, Br J Haematol, 120, 556, 10.1046/j.1365-2141.2003.04049.x George, 2006, Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders, J Clin Apheresis, 21, 49, 10.1002/jca.20091 Cataland, 2005, Immunotherapy for thrombotic thrombocytopenic purpura, Curr Opin Hematol, 12, 359, 10.1097/01.moh.0000170534.33517.99 Wyllie, 2006, Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange, Br J Haematol, 132, 204, 10.1111/j.1365-2141.2005.05857.x Vesely, 2004, Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Transfusion, 44, 1149, 10.1111/j.1537-2995.2004.03422.x Lattuada, 2003, Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome, Haematologica, 88, 1029 Sanchez-Luceros, 2004, von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women, Thromb Haemost, 92, 1320 Schulman, 1960, Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency, Blood, 16, 943, 10.1182/blood.V16.1.943.943 Upshaw, 1978, Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia, N Engl J Med, 298, 1350, 10.1056/NEJM197806152982407 Tsai, 2006, Current concepts in thrombotic thrombocytopenic purpura, Annu Rev Med, 57, 419, 10.1146/annurev.med.57.061804.084505 Plaimauer, 2006, Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation, Blood, 107, 118, 10.1182/blood-2005-06-2482 Shibagaki, 2006, Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failure, Nephrol Dial Transplant, 21, 1289, 10.1093/ndt/gfk072 Tao, 2006, Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura, J Thromb Haemost, 4, 1931, 10.1111/j.1538-7836.2006.02098.x Donadelli, 2006, In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura, Thromb Haemost, 96, 454, 10.1160/TH06-05-0236 Schneppenheim, 2006, A common origin of the 4143insA ADAMTS13 mutation, Thromb Haemost, 96, 3 Noris, 2005, Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement, J Am Soc Nephrol, 16, 1177, 10.1681/ASN.2005010086